Cetuximab (Intravenous Route)


Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Cetuximab (Intravenous Route)

Drug Information provided by: Micromedex

US Brand Names

  • Erbitux

Description

Cetuximab injection is given with radiation treatment and other medicines to treat cancer in the colon and rectal area, and cancer in the head and neck area. This medicine is usually given to patients who have already received other cancer treatments. Cetuximab should only be used in patients with metastatic (cancer that spreads to other parts of the body) colon or rectal cancer who have had a KRAS gene mutation test. This test helps the doctor decide whether the medicine will treat their cancer.

Cetuximab interferes with the growth of cancer cells, which are then destroyed by the body. Since the growth of normal body cells may also be affected by cetuximab, other effects will also occur. Some of these may be serious and must be reported to your doctor. Other effects, such as a skin rash, may not be serious but may cause concern. Some effects do not occur until months or years after the medicine is used.

Before you begin treatment with cetuximab, you and your doctor should talk about the benefits this medicine will do as well as the risks of using it.

This medicine will only be given by or under the immediate supervision of your doctor.

Before Using
DR601857 Portions of this document last updated: Dec. 1, 2011

Source: Drug Information provided by: Micromedex

Copyright © 2013 Thomson Healthcare Inc. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.

Advertisement


Text Size: smaller largerlarger